menu toggle
Why ICS
Insights
Careers
Contact Us
About Us
Who We Are
Why ICS
Our History
Our Leaders
Solutions
Pharmaceutical Warehousing
Order-to-Cash Services
Title Model Solutions
Cell and Gene Therapy
Comparator Sourcing
Performance Analytics
Expert Account Management
Careers
Careers at ICS
Life at ICS
Find Jobs
The AmerisourceBergen Network
Insights
News and Events
Contact Us
LinkedIn
X
Facebook
About Us
Who We Are
Why ICS
Our History
Our Leaders
Solutions
Pharmaceutical Warehousing
Order-to-Cash Services
Title Model Solutions
Cell and Gene Therapy
Comparator Sourcing
Performance Analytics
Expert Account Management
Careers
Careers at ICS
Life at ICS
Find Jobs
The AmerisourceBergen Network
Insights
News and Events
Contact Us
LinkedIn
X
Facebook
Insights
Filter By
All Topics
Analytics
Cash flow management
Cell and gene therapy
Commercial supply chain
Commercialization
Data
Distribution
DSCSA
Financial management
Inventory management
Orphan drugs
Packaging
Quality
Regulatory
Secure supply chain
Technology
Third-party logistics
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
AmerisourceBergen
Financial Management for Cell and Gene Therapies
Albert Cooksey
July 2018
Manufacturers
ICS: Transitioning 3PL Partners
ICS Connect
August 2017
Manufacturers
Three Ways Title Model Powers Pharma Innovation
ICS Connect
May 2017
Manufacturers
ICS: Making a case for Title Model
ICS Connect
January 2017
Manufacturers
Three Critical Components of the Specialty 3PL Experience
ICS Connect
January 2015
brand="Cencora" culture="EN" env="UAT" tracker="False"
